Afatinib Completed Phase 2 Trials for Carcinoma, Squamous Cell of Head and Neck Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01538381Neoadjuvant Afatinib Window Study in Squamous Cell Carcinoma of the Head and Neck